Targeted 3.34-Million CpG Site Sequencing Reveals Preliminary Cord Blood Epigenetic Alterations of Autism Spectrum Disorder: A Pilot Study Highlighting the PCDHA1–PCDHA8 Cluster
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27188038 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Marina Armas-González und 12 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Department, Sección de Medicina, Facultad de Ciencias de la Salud, University of La Laguna (ULL), 38320 La Laguna, Spain. Hauptthemen laut MEDLINE: Fetal Blood, DNA Methylation, Epigenesis, Genetic, CpG Islands. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación, European Regional Development Funds.
Abstract (Originalsprache)
Rising reported Autism Spectrum Disorder (ASD) prevalence underscores the need to explore early perinatal biological markers. To conduct an exploratory pilot investigation of cord blood DNA methylation patterns as potential early epigenetic candidate loci associated with ASD in infants born to mothers with obesity and gestational diabetes. This prospective pilot study analyzed 14 mother-infant pairs comprising infants born to mothers with obesity and gestational diabetes later diagnosed with ASD (n = 2); healthy infants born to mothers with obesity and diabetes (IODM, n = 6); and healthy controls (IHM, n = 6). Targeted methyl-capture sequencing (covering 3.34 million CpG sites) identified differentially methylated region (DMR)-associated genes. Neurodevelopment was evaluated at 24–26 months using Bayley-III scales. ASD infants showed lower Bayley-III scores across all domains. In this small cohort (n = 2 ASD cases), we identified 249 DMR-associated genes common to both ASD vs. IHM and ASD vs. IODM comparisons, representing preliminary candidate loci. Enrichment analysis identified homophilic cell–cell adhesion as the most significant pathway (fold enrichment = 8.28; FDR = 6.31 × 10−6), driven by the PCDH1–PCDHA8 cluster, alongside morphogenesis in neuron differentiation (fold enrichment = 3.45; FDR = 2.08 × 10−2). Although prospective validation in larger independent cohorts is required, these pilot results suggest that cord blood PCDHA1–PCDHA8 cluster methylation alterations represent preliminary candidate loci for hypothesis generation and future biomarker evaluation, regardless of maternal metabolic status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Obstetrics and Gynecology Department, Sección de Medicina, Facultad de Ciencias de la Salud, University of La Laguna (ULL), 38320 La Laguna, Spain.
- Department of Child and Adolescent Psychiatry, Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
- Mathematics, Statistics and Operations Research Department (IMAULL), University of La Laguna (ULL), 38320 La Laguna, Spain.
- Department of Obstetrics and Gynecology, Canary Islands University Hospital, 38320 La Laguna, Spain.
- Pediatrics Department, Canary Islands University Hospital, 38320 La Laguna, Spain.
- Research Unit, Hospital Universitario Ntra. Sra. de Candelaria, Instituto de Investigación Sanitaria de Canarias (IISC), 38010 Santa Cruz de Tenerife, Spain.
ORCID-Profile: Nieves Luisa González-González, Enrique González-Dávila, José Ramón Castro-Conde, Carlos Flores, José Miguel Lorenzo-Salazar, Rafaela González-Montelongo, Adrián Muñoz-Barrera, Erika Padrón-Pérez, Laura Tascón-Padrón
Förderung
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación
- European Regional Development Funds
- Instituto Tecnológico y de Energías Renovables
- Cabildo Insular de Tenerife
Zitieren
APA
Armas-González, M., González-González, N. L., González-Dávila, E., Orribo-Morales, O., Castro-Conde, J. R., González-Campos, C., Flores, C., Lorenzo-Salazar, J. M., González-Montelongo, R., Muñoz-Barrera, A., Padrón-Pérez, E., Tascón-Padrón, L., & Núñez Catalán, M. (2026). Targeted 3.34-Million CpG Site Sequencing Reveals Preliminary Cord Blood Epigenetic Alterations of Autism Spectrum Disorder: A Pilot Study Highlighting the PCDHA1–PCDHA8 Cluster. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27188038
Vancouver
Armas-González M, González-González NL, González-Dávila E, Orribo-Morales O, Castro-Conde JR, González-Campos C, et al. Targeted 3.34-Million CpG Site Sequencing Reveals Preliminary Cord Blood Epigenetic Alterations of Autism Spectrum Disorder: A Pilot Study Highlighting the PCDHA1–PCDHA8 Cluster. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27188038
BibTeX
@article{ArmasGonzlez2026,
author = {Armas-González, Marina and González-González, Nieves Luisa and González-Dávila, Enrique and Orribo-Morales, Olivia and Castro-Conde, José Ramón and González-Campos, Candelaria and Flores, Carlos and Lorenzo-Salazar, José Miguel and González-Montelongo, Rafaela and Muñoz-Barrera, Adrián and Padrón-Pérez, Erika and Tascón-Padrón, Laura and Núñez Catalán, María},
title = {Targeted 3.34-Million CpG Site Sequencing Reveals Preliminary Cord Blood Epigenetic Alterations of Autism Spectrum Disorder: A Pilot Study Highlighting the PCDHA1–PCDHA8 Cluster},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27188038}
}
EUVIMED